Creative Planning - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 126 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
Creative Planning ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q3 2023$3,260
-74.2%
24,7370.0%0.00%
Q2 2023$12,616
-19.0%
24,737
+0.0%
0.00%
Q1 2023$15,582
+7.8%
24,733
+11.0%
0.00%
Q4 2022$14,460
-67.9%
22,277
-15.1%
0.00%
Q3 2022$45,000
+40.6%
26,237
+0.2%
0.00%
Q2 2022$32,000
+88.2%
26,187
+1.2%
0.00%
Q1 2022$17,000
-43.3%
25,887
-5.4%
0.00%
Q4 2021$30,000
-40.0%
27,358
-1.1%
0.00%
Q3 2021$50,000
-26.5%
27,670
+7.0%
0.00%
Q2 2021$68,000
-37.0%
25,858
-31.8%
0.00%
Q1 2021$108,000
+47.9%
37,898
+30.5%
0.00%
Q4 2020$73,000
-3.9%
29,040
-3.3%
0.00%
Q3 2020$76,000
-23.2%
30,0400.0%0.00%
Q2 2020$99,000
+13.8%
30,040
-15.5%
0.00%
Q1 2020$87,000
-44.2%
35,548
+7.6%
0.00%
Q4 2019$156,000
-56.3%
33,048
-60.3%
0.00%
-100.0%
Q3 2019$357,000
-32.0%
83,320
-7.5%
0.00%
-50.0%
Q2 2019$525,000
+81.7%
90,120
+20.0%
0.00%
+100.0%
Q1 2019$289,000
+155.8%
75,120
+24.8%
0.00%
Q4 2018$113,000
-50.0%
60,196
-14.7%
0.00%
-100.0%
Q3 2018$226,000
+6.1%
70,601
-0.0%
0.00%0.0%
Q2 2018$213,000
-22.0%
70,621
+1.4%
0.00%0.0%
Q1 2018$273,000
-5.5%
69,621
-0.3%
0.00%0.0%
Q4 2017$289,000
-21.0%
69,829
+17.0%
0.00%
-50.0%
Q3 2017$366,000
-3.4%
59,671
-2.0%
0.00%0.0%
Q2 2017$379,000
+3.3%
60,863
+5.2%
0.00%0.0%
Q1 2017$367,000
+358.8%
57,863
+289.3%
0.00%
Q4 2016$80,000
+29.0%
14,863
+35.6%
0.00%
Q3 2016$62,000
-63.3%
10,964
-64.5%
0.00%
-100.0%
Q2 2016$169,000
+111.2%
30,864
+185.1%
0.00%0.0%
Q1 2016$80,000
+23.1%
10,824
+37.9%
0.00%0.0%
Q4 2015$65,000
-12.2%
7,848
-3.9%
0.00%0.0%
Q3 2015$74,000
+572.7%
8,166
+716.6%
0.00%
Q1 2015$11,000
+1000.0%
1,000
+150.0%
0.00%
Q3 2014$1,000
-96.2%
400
-93.3%
0.00%
Q4 2013$26,0006,0000.00%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q3 2022
NameSharesValueWeighting ↓
Third Security, LLC 17,815,708$47,033,0002.93%
Essex Woodlands Management, Inc. 2,764,908$7,130,0002.60%
Belmont Global Advisors, Inc. 973,000$2,569,0002.01%
Belmont Global Advisors, Inc. 135,700$358,0000.28%
MSD Partners, L.P. 2,750,000$7,260,0000.22%
SFMG, LLC 99,850$264,0000.08%
Rotella Capital Management, Inc. 11,090$29,0000.03%
WESTPORT RESOURCES MANAGEMENT INC 33,500$88,0000.02%
SMITH ASSET MANAGEMENT GROUP LP 236,590$625,0000.02%
FRANKLIN STREET ADVISORS INC /NC 41,150$109,0000.02%
View complete list of ZIOPHARM ONCOLOGY INC shareholders